Three-dimensional organization of promyelocytic leukemia nuclear bodies

Journal of Cell Science

Volumn 123, Issue 3, 2010, Pages 392-400

  Lang, Marion ^a,b   Jegou, Thibaud ^a,b   Chung, Inn ^a,b   Richter, Karsten ^a   Münch, Sandra ^c   Udvarhelyi, Anikó ^a,b   Cremer, Christoph ^b   Hemmerich, Peter ^c   Engelhardt, Johann ^a,b   Hell, Stefan W ^a,b,d   Rippe, Karsten ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c FRITZ LIPMANN INSTITUTE   (Germany)

^d MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

4Pi microscopy; Promyelocytic leukemia nuclear bodies; Sumoylation

Indexed keywords

HETEROCHROMATIN PROTEIN 1; NUCLEAR PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN SP100; SUMO PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL COMPARTMENTALIZATION; CELL NUCLEUS INCLUSION BODY; CELL SHAPE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INTERPHASE; LASER MICROSCOPY; MOLECULAR IMAGING; MOLECULAR SIZE; OPTICAL RESOLUTION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN ASSEMBLY; PROTEIN LOCALIZATION; PROTEIN PROCESSING; TELOMERE; THREE DIMENSIONAL IMAGING;

ANTIGENS, NUCLEAR; AUTOANTIGENS; CELL LINE, TUMOR; HELA CELLS; HUMANS; INTRANUCLEAR INCLUSION BODIES; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMO-1 PROTEIN; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITINS;

EID: 76649083577     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.053496     Document Type: Article

References (67)

1. Bernardi, R. and Pandolfi, P. P. (2007). Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell. Biol. 8, 1006-1016.
2. Bewersdorf, J., Bennett, B. and Knight, K. (2006). H2AX chromatin structures and their response to DNA damage revealed by 4Pi microscopy. Proc. Natl. Acad. Sci. USA 103, 18137-18142.
3. Boisvert, F. M., Hendzel, M. J. and Bazett-Jones, D. P. (2000a). Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J. Cell Biol. 148, 283-292.
4. Boisvert, F. M., Hendzel, M. J. and Bazett-Jones, D. P. (2000b). Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J. Cell Biol. 148, 283-292.
5. Borden, K. L. (2002). Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol. Cell. Biol. 22, 5259-5269.
6. Borden, K. L. (2008). Pondering the puzzle of PML (promyelocytic leukemia) nuclear bodies: can we fit the pieces together using an RNA regulon? Biochim. Biophys. Acta 1783, 2145-2154.
7. Borden, K. L., Lally, J. M., Martin, S. R., O'Reilly, N. J., Solomon, E. and Freemont, P. S. (1996). In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML. Proc. Natl. Acad. Sci. USA 93, 1601-1606.
8. Dellaire, G. and Bazett-Jones, D. P. (2004). PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. BioEssays 26, 963-977.
9. Egner, A., Jakobs, S. and Hell, S. W. (2002). Fast 100-nm resolution 3D-microscope reveals structural plasticity of mitochondria in live yeast. Proc. Natl. Acad. Sci. USA 99, 3370-3375.
10. Everett, R. D. and Murray, J. (2005). ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J. Virol. 79, 5078-5089.
11. Everett, R. D., Lomonte, P., Sternsdorf, T., van Driel, R. and Orr, A. (1999). Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112, 4581-4588.
12. Everett, R. D., Rechter, S., Papior, P., Tavalai, N., Stamminger, T. and Orr, A. (2006). PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J. Virol. 80, 7995-8005.
13. Failla, A. V., Spoeri, U., Albrecht, B., Kroll, A. and Cremer, C. (2002). Nanosizing of fluorescent objects by spatially modulated illumination microscopy. Appl. Optics 41, 7275-7283.
14. Fu, C., Ahmed, K., Ding, H., Ding, X., Lan, J., Yang, Z., Miao, Y., Zhu, Y., Shi, Y., Zhu, J. et al. (2005). Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene 24, 5401-5413.
15. Goddard, A. D., Borrow, J., Freemont, P. S. and Solomon, E. (1991). Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254, 1371-1374.
16. Görisch, S. M., Wachsmuth, M., Ittrich, C., Bacher, C. P., Rippe, K. and Lichter, P. (2004). Nuclear body movement is determined by chromatin accessibility and dynamics. Proc. Natl. Acad. Sci. USA 101, 13221-13226.
17. Görisch, S. M., Wachsmuth, M., Fejes Tóth, K., Lichter, P. and Rippe, K. (2005). Histone acetylation increases chromatin accessibility. J. Cell Sci. 118, 5825-5834.
18. Gugel, H., Bewersdorf, J., Jakobs, S., Engelhardt, J., Storz, R. and Hell, S. W. (2004). Cooperative 4Pi excitation and detection yields 7-fold sharper optical sections in live cell microscopy. Biophys. J. 87, 4146-4152.
19. Hell, S. W. (2007). Far-field optical nanoscopy. Science 316, 1153-1158.
20. Hell, S. and Stelzer, E. H. K. (1992). Properties of a 4Pi-confocal fluorescence microscope. J. Opt. Soc. Am. A. 9, 2159-2166.
21. Hüve, J., Wesselmann, R., Kahms, M. and Peters, R. (2008). 4Pi microscopy of the nuclear pore complex. Biophys. J. 95, 877-885.
22. Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T., Strauss, J. F., 3rd and Maul, G. G. (1999). PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147, 221-234.
23. Jegou, T., Chung, I., Heuvelmann, G., Wachsmuth, M., Görisch, S. M., Greulich-Bode, K., Boukamp, P., Lichter, P. and Rippe, K. (2009). Dynamics of telomeres and promyelocytic leukemia nuclear bodies in a telomerase negative human cell line. Mol. Biol. Cell 20, 2070-2082.
24. Kamitani, T., Kito, K., Nguyen, H. P., Wada, H., Fukuda-Kamitani, T. and Yeh, E. T. (1998a). Identification of three major sentrinization sites in PML. J. Biol. Chem. 273, 26675-26682.
25. Kamitani, T., Nguyen, H. P., Kito, K., Fukuda-Kamitani, T. and Yeh, E. T. (1998b). Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J. Biol. Chem. 273, 3117-3120.
26. Kastner, P., Perez, A., Lutz, Y., Rochette-Egly, C., Gaub, M. P., Durand, B., Lanotte, M., Berger, R. and Chambon, P. (1992). Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J. 11, 629-642.
27. Kentsis, A., Gordon, R. E. and Borden, K. L. (2002). Self-assembly properties of a model RING domain. Proc. Natl. Acad. Sci. USA 99, 667-672.
28. Koken, M. H., Puvion-Dutilleul, F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., Chomienne, C. et al. (1994). The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13, 1073-1083.
29. Kostarelos, K. and Miller, A. D. (2005). Synthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors. Chem. Soc. Rev. 34, 970-994.
30. Lallemand-Breitenbach, V., Zhu, J., Puvion, F., Koken, M., Honore, N., Doubeikovsky, A., Duprez, E., Pandolfi, P. P., Puvion, E., Freemont, P. et al. (2001). Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 193, 1361-1371.
31. Lallemand-Breitenbach, V., Jeanne, M., Benhenda, S., Nasr, R., Lei, M., Peres, L., Zhou, J., Zhu, J., Raught, B. and de The, H. (2008). Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat. Cell Biol. 10, 547-555.
32. Lang, M., Engelhardt, J. and Hell, S. W. (2007a). 4Pi microscopy with linear fluorescence excitation. Opt. Lett. 32, 259-261.
33. Lang, M., Müller, T., Engelhardt, J. and Hell, S. W. (2007b). 4Pi microscopy of type A with 1-photon excitation in biological fluorescence imaging. Opt. Express 15, 2459-2467.
34. Le, X. F., Yang, P. and Chang, K. S. (1996). Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J. Biol. Chem. 271, 130-135.
35. Lin, D. Y., Huang, Y. S., Jeng, J. C., Kuo, H. Y., Chang, C. C., Chao, T. T., Ho, C. C., Chen, Y. C., Lin, T. P., Fang, H. I. et al. (2006). Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell 24, 341-354.
36. Louria-Hayon, I., Grossman, T., Sionov, R. V., Alsheich, O., Pandolfi, P. P. and Haupt, Y. (2003). The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation. J. Biol. Chem. 278, 33134-33141.
37. Luciani, J. J., Depetris, D., Usson, Y., Metzler-Guillemain, C., Mignon-Ravix, C., Mitchell, M. J., Megarbane, A., Sarda, P., Sirma, H., Moncla, A. et al. (2006). PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase. J. Cell Sci. 119, 2518-2531.
38. Matic, I., van Hagen, M., Schimmel, J., Macek, B., Ogg, S. C., Tatham, M. H., Hay, R. T., Lamond, A. I., Mann, M. and Vertegaal, A. C. (2008). In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol. Cell Proteomics 7, 132-144.
39. Melnick, A. and Licht, J. D. (1999). Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93, 3167-3215.
40. Müller, K., Erdel, F., Caudron-Herger, M., Marth, C., Fodor, B. D., Richter, M., Scaranaro, M., Beoudoin, J., Wachsmuth, M. and Rippe, K. (2009). A multi-scale analysis of dynamics and interactions of heterochromatin protein 1 in the nucleus by fluorescence fluctuation microscopy. Biophy. J. 97, 2876-2885.
41. Nacerddine, K., Lehembre, F., Bhaumik, M., Artus, J., Cohen-Tannoudji, M., Babinet, C., Pandolfi, P. P. and Dejean, A. (2005). The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev. Cell 9, 769-779.
42. Nagorni, M. and Hell, S. W. (2001). Coherent use of opposing lenses for axial resolution increase in fluorescence microscopy. II. Power and limitation of nonlinear image restoration. J. Opt. Soc. Am. A 18, 49-54.
43. Neumann, A. A. and Reddel, R. R. (2006). Telomerase-independent maintenance of mammalian telomeres. In Telomeres (eds T. de Lange, V. Lundblad and E. Blackburn), pp. 163-198. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
44. Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P. et al. (2000). PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406, 207-210.
45. Perez, A., Kastner, P., Sethi, S., Lutz, Y., Reibel, C. and Chambon, P. (1993). PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR. EMBO J. 12, 3171-3182.
46. Potts, P. R. and Yu, H. (2007). The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins. Nat. Struct. Mol. Biol. 14, 581-590.
47. Quimby, B. B., Yong-Gonzalez, V., Anan, T., Strunnikov, A. V. and Dasso, M. (2006). The promyelocytic leukemia protein stimulates SUMO conjugation in yeast. Oncogene 25, 2999-3005.
48. Richards, B. and Wolf, E. (1959). Electromagnetic diffraction in optical systems II. Structure of the image field in an aplanatic system. Proc. R. Soc. Lond. A 253, 358-379.
49. Richter, K., Reichenzeller, M., Gorisch, S. M., Schmidt, U., Scheuermann, M. O., Herrmann, H. and Lichter, P. (2005). Characterization of a nuclear compartment shared by nuclear bodies applying ectopic protein expression and correlative light and electron microscopy. Exp. Cell Res. 303, 128-137.
50. Saitoh, N., Uchimura, Y., Tachibana, T., Sugahara, S., Saitoh, H. and Nakao, M. (2006). In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies. Exp. Cell Res. 312, 1418-1430.
51. Salomoni, P. and Pandolfi, P. P. (2002). The role of PML in tumor suppression. Cell 108, 165-170.
52. Salomoni, P., Ferguson, B. J., Wyllie, A. H. and Rich, T. (2008). New insights into the role of PML in tumour suppression. Cell Res. 18, 622-640.
53. Schmiedeberg, L., Weisshart, K., Diekmann, S., Meyer zu Hoerste, G. and Hemmerich, P. (2004). High- and low-mobility populations of HP1 in heterochromatin of mammalian cells. Mol. Biol. Cell 15, 2819-2833.
54. Seeler, J. S., Marchio, A., Losson, R., Desterro, J. M., Hay, R. T., Chambon, P. and Dejean, A. (2001). Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification. Mol. Cell. Biol. 21, 3314-3324.
55. Shen, T. H., Lin, H. K., Scaglioni, P. P., Yung, T. M. and Pandolfi, P. P. (2006). The mechanisms of PML-nuclear body formation. Mol. Cell 24, 331-339.
56. Song, J., Durrin, L. K., Wilkinson, T. A., Krontiris, T. G. and Chen, Y. (2004). Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl. Acad. Sci. USA 101, 14373-14378.
57. Staudt, T., Lang, M., Medda, R., Engelhardt, J. and Hell, S. W. (2007). 2,2′-Thiodiethanol: a new water soluble mounting medium for high resolution optical microscopy. Microsc. Res. Tech. 70, 1-9.
58. Sternsdorf, T., Jensen, K. and Will, H. (1997). Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol. 139, 1621-1634.
59. Sternsdorf, T., Jensen, K., Reich, B. and Will, H. (1999). The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 274, 12555-12566.
60. Takahashi, Y., Lallemand-Breitenbach, V., Zhu, J. and de The, H. (2004). PML nuclear bodies and apoptosis. Oncogene 23, 2819-2824.
61. Tatham, M. H., Geoffroy, M. C., Shen, L., Plechanovova, A., Hattersley, N., Jaffray, E. G., Palvimo, J. J. and Hay, R. T. (2008). RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 10, 538-546.
62. Uchimura, Y., Ichimura, T., Uwada, J., Tachibana, T., Sugahara, S., Nakao, M. and Saitoh, H. (2006). Involvement of SUMO modification in MBD1- and MCAF1-mediated heterochromatin formation. J. Biol. Chem. 281, 23180-23190.
63. Weidtkamp-Peters, S., Lenser, T., Negorev, D., Gerstner, N., Hofmann, T. G., Schwanitz, G., Hoischen, C., Maul, G., Dittrich, P. and Hemmerich, P. (2008). Dynamics of component exchange at PML nuclear bodies. J. Cell Sci. 121, 2731-2743.
64. Weidtkamp-Peters, S., Weisshart, K., Schmiedeberg, L. and Hemmerich, P. (2009). Fluorescence correlation spectroscopy to assess the mobility of nuclear proteins. Methods Mol. Biol. 464, 321-341.
65. Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A. and Dejean, A. (1994). Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 76, 345-356.
66. Yeager, T. R., Neumann, A. A., Englezou, A., Huschtscha, L. I., Noble, J. R. and Reddel, R. R. (1999). Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59, 4175-4179.
67. Zhong, S., Muller, S., Ronchetti, S., Freemont, P. S., Dejean, A. and Pandolfi, P. P. (2000). Role of SUMO-1-modified PML in nuclear body formation. Blood 95, 2748-2752.